Roxadustat capsules | China Drugs List
Public reference information, not medical advice, a prescription or an offer to supply a medicine. Confirm current approval, availability and suitability with licensed professionals.
- Medicine type
- Chemical medicine
- Therapeutic area
- Kidney diseases
- Indications recorded in the public source
- Treatment of anemia caused by chronic kidney disease (CKD), in both dialysis-dependent and non-dialysis-dependent patients. This summary was checked against prescribing information for a generic product from Chengdu Guowei with the same active ingredient; the complete originator-brand prescribing information is still unavailable.
- Indication source and scope
- Source date(s): 2025-07-31. Manufacturer prescribing information for Mainland China. Generic label from Chengdu Guowei; not the originator brand.
- Prescribing-information limitations
- Complete Chinese label obtained for a generic with the same ingredient. The originator brand label remains unavailable.
- China availability status
- Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- Overseas status
- Japan: local approval / launch announcements and official price sources obtained. Indications and dates are specified in each price record; other markets not exhaustively reviewed.
- Insurance classification
- Included in national insurance (Category B)
- Insurance edition
- 2025 edition; effective 1 January 2026
- Insurance restrictions
- Limited to anemia caused by CKD.
- Insurance verification notes
- Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.
Sources
- https://m.cnpharm.com/c/2019-07-01/497890.shtml
- https://www.nhsa.gov.cn/module/download/downfile.jsp?classid=0&filename=a32f9f2f3fc046afaf08471f87456ce3.pdf
- https://drug.cdgowell.com/UpLoadFiles/20250811/2025081110311550.pdf
Open the interactive record, public price references and discussions